Answer
The geometric mean terminal half-life of turoctocog alfa pegol (Esperoct) in previously treated adults aged ≥18 years with severe haemophilia A was 19.9 hours (CV 34%), measured using a chromogenic assay after a single 50 IU/kg dose.
Sources for this answer
- Esperoct 1000 IU powder and solvent for solution for injectionNovo Nordisk Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked